Prime Medicine to Participate in Upcoming Investor Conferences

About this update from Prime Medicine, Inc.

[{"type":"image","alt":"Prime Medicine, Inc.","displaySize":"","headline":null,"caption":"Prime Medicine, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":100,"url":"https://media.zenfs.com/en/globenewswire.com/7c5397d80babf7cd71ba3f6a787c0b3f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/S_7U4Aj8CXur3GvYQq2zOQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7c5397d80babf7cd71ba3f6a787c0b3f","width":300,"height":100}},"lazy":false},{"type":"text","content":"CAMBRIDGE, Mass., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that company management will participate in two upcoming conferences:","length":289,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"H.C. Wainwright Genetic Medicines Virtual Conference 2025: Fireside chat will be available to view on demand beginning Tuesday, October 14, 2025. Company management will host virtual 1x1 meetings on Wednesday, October 15, 2025.","length":227,"tagName":"p"}]},{"val":[{"type":"text","content":"Chardan’s 9th Annual Genetic Medicines Conference: Allan Reine, M.D., will participate in a panel discussion, “Genome Editing: Next Wave Technologies,” and host 1x1 meetings on Tuesday, October 21, 2025, at 8:45 a.m. ET in New York, NY.","length":236,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":463,"olType":false},{"type":"text","content":"Live audio webcasts of the fireside chat and panel discussion will be available under “Events & Presentations” in the News & Events section of the Company’s website at www.primemedicine.com. Replays of each webcast will be available on the Prime Medicine website for 90 days following the event.","length":303,"tagName":"p"},{"type":"text","content":"About Prime Medicine","length":20,"tagName":"p"},{"type":"text","content":"Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients. The Company is deploying its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology, to develop a new class of differentiated one-time curative genetic therapies. Designed to make only the ...

More updates from Prime Medicine, Inc.